4//SEC Filing
Snyder Lori A 4
Accession 0000790051-24-000056
CIK 0000790051other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 2:45 PM ET
Size
55.7 KB
Accession
0000790051-24-000056
Insider Transaction Report
Form 4
Snyder Lori A
V. P., Human Resources
Transactions
- Exercise/Conversion
Common Stock
2024-02-08$108.72/sh+472$51,316→ 5,684 total - Sale
Common Stock
2024-02-08$338.52/sh−472$159,781→ 5,212 total - Exercise/Conversion
Common Stock
2024-02-08$110.79/sh+1,247$138,155→ 6,459 total - Exercise/Conversion
Common Stock
2024-02-08$161.41/sh+1,385$223,553→ 6,597 total - Sale
Common Stock
2024-02-08$339.34/sh−1,385$469,986→ 5,212 total - Exercise/Conversion
Common Stock
2024-02-08$222.35/sh+1,560$346,866→ 6,772 total - Sale
Common Stock
2024-02-08$339.96/sh−1,560$530,338→ 5,212 total - Exercise/Conversion
Common Stock
2024-02-08$250.86/sh+837$209,970→ 6,049 total - Sale
Common Stock
2024-02-08$340.27/sh−837$284,806→ 5,212 total - Exercise/Conversion
Common Stock
2024-02-08$161.41/sh+243$39,223→ 898 total(indirect: By Spouse) - Sale
Common Stock
2024-02-08$337.01/sh−243$81,893→ 655 total(indirect: By Spouse) - Exercise/Conversion
Common Stock
2024-02-08$150.00/sh+345$51,750→ 1,000 total(indirect: By Spouse) - Sale
Common Stock
2024-02-08$337.28/sh−345$116,362→ 655 total(indirect: By Spouse) - Exercise/Conversion
Common Stock
2024-02-08$222.35/sh+150$33,353→ 805 total(indirect: By Spouse) - Sale
Common Stock
2024-02-08$337.71/sh−150$50,657→ 655 total(indirect: By Spouse) - Sale
Common Stock
2024-02-08$338.00/sh−57$19,266→ 655 total(indirect: By Spouse) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−2,600→ 0 totalExercise: $150.00Exp: 2031-02-01→ Common Stock (2,600 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−1,560→ 780 totalExercise: $222.35Exp: 2032-02-07→ Common Stock (1,560 underlying) - Sale
Common Stock
2024-02-08$338.88/sh−1,247$422,583→ 5,212 total - Sale
Common Stock
2024-02-08$339.96/sh−2,600$883,896→ 5,212 total - Exercise/Conversion
Common Stock
2024-02-08$250.86/sh+57$14,299→ 712 total(indirect: By Spouse) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−472→ 0 totalExercise: $108.72From: 2021-02-06Exp: 2028-02-05→ Common Stock (472 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−1,247→ 0 totalExercise: $110.79Exp: 2029-02-04→ Common Stock (1,247 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−1,385→ 0 totalExercise: $161.41Exp: 2030-02-03→ Common Stock (1,385 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−837→ 1,673 totalExercise: $250.86Exp: 2033-01-30→ Common Stock (837 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−243→ 0 total(indirect: By Spouse)Exercise: $161.41Exp: 2030-02-03→ Common Stock (243 underlying) - Exercise/Conversion
Common Stock
2024-02-08$150.00/sh+2,600$390,000→ 7,812 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−345→ 0 total(indirect: By Spouse)Exercise: $150.00Exp: 2031-02-01→ Common Stock (345 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−150→ 75 total(indirect: By Spouse)Exercise: $222.35Exp: 2032-02-07→ Common Stock (150 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-02-08−57→ 113 total(indirect: By Spouse)Exercise: $250.86Exp: 2033-01-30→ Common Stock (57 underlying)
Footnotes (13)
- [F1]This transaction was executed in multiple trades at prices ranging from $338.42 to $338.63. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F10]The option vests in three equal annual installments beginning on February 2, 2022.
- [F11]The option vests in three equal annual installments beginning on February 8, 2023.
- [F12]The option vests in three equal annual installments beginning on January 31, 2024.
- [F13]The option vests in three equal annual installments beginning on February 4, 2021, of which 122 options were exercised on October 25, 2021 for which a Form 4 was inadvertently not filed previously by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $338.63 to $339.07. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F3]This transaction was executed in multiple trades at prices ranging from $339.07 to $339.96. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F4]This transaction was executed in multiple trades at prices ranging from $339.96 to $340.47. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F5]This transaction was executed in multiple trades at prices ranging from $337.01 to $337.51. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F6]This transaction was executed in multiple trades at prices ranging from $337.51 to $338.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F7]The transaction is the exercise of a derivative security.
- [F8]The option vests in two equal annual installments beginning on February 5, 2021.
- [F9]The option vests in three equal annual installments beginning on February 4, 2021.
Documents
Issuer
CARLISLE COMPANIES INC
CIK 0000790051
Entity typeother
Related Parties
1- filerCIK 0001838094
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 2:45 PM ET
- Size
- 55.7 KB